Genetics terminology for respiratory physicians

International Human Genome Sequencing Consortium, 2004, Finishing the euchromatic sequence of the human genome, Nature, 431, 931, 10.1038/nature03001 NHS Genetics White Paper. “Our Inheritance – Our Future”: Realising the potential of Genetics in the NHS. UK: Department of Health 2003. Family Health History Initiative. National Human Genome Research Institute and Office of Surgeon General, Department of Health and Human Services. 2004. Collins, 2003, A vision for the future of genomics research, Nature, 422, 835, 10.1038/nature01626 Watson, 1953, Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid, Nature, 171, 737, 10.1038/171737a0 Birney, 2007, Identification and analysis of functional elements in 1% of the human genome by the ENCODE project, Nature, 447, 799, 10.1038/nature05874 Bobadilla, 2002, Cystic Fibrosis: A worldwide analysis of CFTR mutations – correlation with incidence data and application to screening, Human Mutation, 19, 575, 10.1002/humu.10041 Riordan, 1989, Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA, Science, 245, 1066, 10.1126/science.2475911 McIntosh, 1992, Cystic fibrosis transmembrane conductance regulator and the etiology and pathogenesis of cystic fibrosis, FASEB J, 6, 2775, 10.1096/fasebj.6.10.1378801 CF Mutation database: http://www.genet.sickkids.on.ca/cftr/. Ogino, 2007, Standard Mutation nomenclature in molecular diagnostics, J Mol Diagn, 9, 1, 10.2353/jmoldx.2007.060081 Kerem, 1996, Genotype-phenotype correlations in cystic fibrosis, Pediatr Pulm, 20, 387, 10.1002/(SICI)1099-0496(199612)22:6<387::AID-PPUL7>3.0.CO;2-G Rowntree, 2003, The phenotypic consequences of CFTR mutations, Ann Hum Genet, 67, 471, 10.1046/j.1469-1809.2003.00028.x Rowe, 2005, Mechanisms of disease. Cystic Fibrosis, NEJM, 19, 1992, 10.1056/NEJMra043184 Welsh, 1993, Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis, Cell, 73, 1251, 10.1016/0092-8674(93)90353-R Wilschanski, 1995, Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations, J Pediat, 127, 705, 10.1016/S0022-3476(95)70157-5 Noone, 2000, Lung disease associated with the IVS8 5T allele of the CFTR gene, Am J Respir Crit Care Med, 162, 1919, 10.1164/ajrccm.162.5.2003160 Collaco, 2008, Update on genetic modifiers in cystic fibrosis, Curr Opin Pulm Med, 14, 559, 10.1097/MCP.0b013e3283121cdc Griffin, 2005, The genetic and cytogenetic basis of male infertility, Human Fertility, 8, 19, 10.1080/14647270400016407 Proesmans, 2008, What's new in cystic fibrosis? From treating symptoms to correction of the basic defect, Eur J Pediatr, 167, 839, 10.1007/s00431-008-0693-2 Dork, 1997, Distinct spectrum of CFTR gene mutations in congenital absence of the vas deferens, Hum Genet, 100, 365, 10.1007/s004390050518 Claustres, 2000, Spectrum of CFTR mutations in cystric fibrosis and in congenital absence of the vas deferens in France, Hum Mutat, 16, 143, 10.1002/1098-1004(200008)16:2<143::AID-HUMU7>3.0.CO;2-J Wang, 2002, Analysis by mass spectrometry of 100 cystic fibrosis gene mutations in 92 patients with congenital absence of the vas deferens, Hum Reprod, 17, 2066, 10.1093/humrep/17.8.2066 Moskowitz SM, Chmiel JF, Sternen DL, et al. Gene reviews – CFTR related disorders 2008. University of Washington, Seattle at http://www.genetests.org. Moffat, 2008, Genes in asthma: new genes and new ways, Curr Opin Allergy Clin Immunol, 8, 411, 10.1097/ACI.0b013e32830f1dc1 Vercelli, 2008, Discovering susceptibility genes for asthma and allergy, Nat Rev Immunol, 8, 169, 10.1038/nri2257 Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062 Schork, 2000, Single nucleotide polymorphisms and the future of genetic epidemiology, Clin Genet, 58, 250, 10.1034/j.1399-0004.2000.580402.x Jeffreys, 1985, Hypervariable minisatellite regions in human DNA, Nature, 314, 67, 10.1038/314067a0 Frazer, 2007, International HapMap consortium. A second generation human haplotype map of over 3.2 million SNPs, Nature, 449, 851, 10.1038/nature06258 Beckmann, 2001, Copy number variants and genetics traits: closer to resolutions of phenotypic to genotypic variability, Nature, 8, 639 Weber, 1989, Abundant class of DNA polymorphisms which can be typed using polymerase chain reaction, Am J Hum Genet, 44, 388 Botstein, 1980, Construction of a genetic linkage map using restriction fragment length polymorphisms, Am J Hum Genet, 32, 314 Orr, 2008, Common Genetic Variation and Human Disease, Adv in Genetics, 62, 1, 10.1016/S0065-2660(08)00601-9 Krawezak, 1992, The mutational spectrum of single base-pair nucleotides in mRNA splice junctions of human genes: cause and consequences, Hum Genet, 90, 41 Sachidanandam, 2001, A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms, Nature, 409, 928, 10.1038/35057149 FeukL, 2006, Structural variation in the human genome, Nat Rev. Genet, 7, 85, 10.1038/nrg1767 Sebat, 2004, Large-scale copy number polymorphism in the human genome, Science, 305, 525, 10.1126/science.1098918 Sebat, 2007, Strong association of de novo copy number mutations with autism, Science, 316, 848, 10.1126/science.1138659 Stranger, 2007, Relative impact of nucleotides and copy number variation on gene expression phenotypes, Science, 315, 848, 10.1126/science.1136678 Kerem, 1989, Identification of the cystic fibrosis gene: genetic analysis, Science, 245, 1073, 10.1126/science.2570460 Conrad, 2006, A worldwide survey of haplotype variation and linkage disequilibrium in the human genome, Nat Genet, 38, 1251, 10.1038/ng1911 International HapMap Project. http://www.hapmap.org. Hopes, 1998, Association of glutamine 27 polymorphism of B2 adrenoceptor with reported childhood asthmas: population based study, BMJ, 316, 664, 10.1136/bmj.316.7132.664 Howard, 2002, Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma, Am J Hum Genet, 70, 230, 10.1086/338242 Moffatt, 2000, Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample, Eur J Hum Genet, 9, 341, 10.1038/sj.ejhg.5200636 Krynetski, 1996, Yates CR> Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms, Pharmacogenetics, 6, 279, 10.1097/00008571-199608000-00001 Corvol, 2008, Pharmacogenetic response to albuterol among asthmatics, Pharmacogenomics, 9, 505, 10.2217/14622416.9.5.505 Israel, 2004, Use of regularly scheduled albuterol treatment in asthma: genotype- stratified, randomised, placebo-controlled cross-over trial, Lancet, 364, 1505, 10.1016/S0140-6736(04)17273-5 Tsai, 2006, Beta 2 adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics, Hum Genet, 119, 547, 10.1007/s00439-006-0169-2 Wenzel, 2007, Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatics: results of two phase 2a studies, Lancet, 370, 1422, 10.1016/S0140-6736(07)61600-6 Tan, 2007, Allele-specific targetting of microRNAs to HLA-G and risk of asthma, AJHG, 81, 829, 10.1086/521200 UK cystic fibrosis gene therapy consortium at http://www.cfgenetherapy.org.uk/. Noone, 2000, Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis, Mol Ther, 1, 105, 10.1006/mthe.1999.0009 Wilschanski, 2003, Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations, NEJM, 349, 1433, 10.1056/NEJMoa022170 PTC Therapeutics company website www.ptcbio.com. US government clinical trials at www.clinicaltrials.gov/. Lukacs, 2003, Pharmacologic Approaches to correcting the basic defect in cystic fibrosis, NEJM, 349, 1401, 10.1056/NEJMp038113 Berger, 2005, Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity, J Biolog Chem, 280, 5221, 10.1074/jbc.M412972200 Evans, 2003, Pharmacogenomics--drug disposition, drug targets, and side effects, New Eng. J. Med., 348, 538, 10.1056/NEJMra020526